These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 25710492)

  • 1. A γ-secretase inhibitor, but not a γ-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP.
    Weissmiller AM; Natera-Naranjo O; Reyna SM; Pearn ML; Zhao X; Nguyen P; Cheng S; Goldstein LS; Tanzi RE; Wagner SL; Mobley WC; Wu C
    PLoS One; 2015; 10(2):e0118379. PubMed ID: 25710492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Γ-secretase modulators do not induce Aβ-rebound and accumulation of β-C-terminal fragment.
    Li T; Huang Y; Jin S; Ye L; Rong N; Yang X; Ding Y; Cheng Z; Zhang J; Wan Z; Harrison DC; Hussain I; Hall A; Lee DH; Lau LF; Matsuoka Y
    J Neurochem; 2012 Apr; 121(2):277-86. PubMed ID: 22035227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
    Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. γ-Secretase inhibitors and modulators.
    Golde TE; Koo EH; Felsenstein KM; Osborne BA; Miele L
    Biochim Biophys Acta; 2013 Dec; 1828(12):2898-907. PubMed ID: 23791707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Amyloid impairs axonal BDNF retrograde trafficking.
    Poon WW; Blurton-Jones M; Tu CH; Feinberg LM; Chabrier MA; Harris JW; Jeon NL; Cotman CW
    Neurobiol Aging; 2011 May; 32(5):821-33. PubMed ID: 19540623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
    Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
    J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. γ-Secretase modulators exhibit selectivity for modulation of APP cleavage but inverse γ-secretase modulators do not.
    Lessard CB; Rodriguez E; Ladd TB; Minter LM; Osborne BA; Miele L; Golde TE; Ran Y
    Alzheimers Res Ther; 2020 May; 12(1):61. PubMed ID: 32430033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrophilic loop 1 of Presenilin-1 and the APP GxxxG transmembrane motif regulate γ-secretase function in generating Alzheimer-causing Aβ peptides.
    Liu L; Lauro BM; Wolfe MS; Selkoe DJ
    J Biol Chem; 2021; 296():100393. PubMed ID: 33571524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise and BDNF reduce Aβ production by enhancing α-secretase processing of APP.
    Nigam SM; Xu S; Kritikou JS; Marosi K; Brodin L; Mattson MP
    J Neurochem; 2017 Jul; 142(2):286-296. PubMed ID: 28382744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and mechanism of γ-secretase modulators for Alzheimer's disease.
    Crump CJ; Johnson DS; Li YM
    Biochemistry; 2013 May; 52(19):3197-216. PubMed ID: 23614767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced β-secretase processing alters APP axonal transport and leads to axonal defects.
    Rodrigues EM; Weissmiller AM; Goldstein LS
    Hum Mol Genet; 2012 Nov; 21(21):4587-601. PubMed ID: 22843498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First and second generation γ-secretase modulators (GSMs) modulate amyloid-β (Aβ) peptide production through different mechanisms.
    Borgegard T; Juréus A; Olsson F; Rosqvist S; Sabirsh A; Rotticci D; Paulsen K; Klintenberg R; Yan H; Waldman M; Stromberg K; Nord J; Johansson J; Regner A; Parpal S; Malinowsky D; Radesater AC; Li T; Singh R; Eriksson H; Lundkvist J
    J Biol Chem; 2012 Apr; 287(15):11810-9. PubMed ID: 22334705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. γ-Secretase in Alzheimer's disease.
    Hur JY
    Exp Mol Med; 2022 Apr; 54(4):433-446. PubMed ID: 35396575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-amyloid precursor protein mutants respond to gamma-secretase modulators.
    Page RM; Gutsmiedl A; Fukumori A; Winkler E; Haass C; Steiner H
    J Biol Chem; 2010 Jun; 285(23):17798-810. PubMed ID: 20348104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An improved cell-based method for determining the γ-secretase enzyme activity against both Notch and APP substrates.
    McKee TD; Loureiro RM; Dumin JA; Zarayskiy V; Tate B
    J Neurosci Methods; 2013 Feb; 213(1):14-21. PubMed ID: 23219895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of γ-secretase worsens memory deficits in a genetically congruous mouse model of Danish dementia.
    Tamayev R; D'Adamio L
    Mol Neurodegener; 2012 Apr; 7():19. PubMed ID: 22537414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate-targeting gamma-secretase modulators.
    Kukar TL; Ladd TB; Bann MA; Fraering PC; Narlawar R; Maharvi GM; Healy B; Chapman R; Welzel AT; Price RW; Moore B; Rangachari V; Cusack B; Eriksen J; Jansen-West K; Verbeeck C; Yager D; Eckman C; Ye W; Sagi S; Cottrell BA; Torpey J; Rosenberry TL; Fauq A; Wolfe MS; Schmidt B; Walsh DM; Koo EH; Golde TE
    Nature; 2008 Jun; 453(7197):925-9. PubMed ID: 18548070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclopamine modulates γ-secretase-mediated cleavage of amyloid precursor protein by altering its subcellular trafficking and lysosomal degradation.
    Vorobyeva AG; Lee R; Miller S; Longen C; Sharoni M; Kandelwal PJ; Kim FJ; Marenda DR; Saunders AJ
    J Biol Chem; 2014 Nov; 289(48):33258-74. PubMed ID: 25281744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific Inhibition of β-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein.
    Ben Halima S; Mishra S; Raja KMP; Willem M; Baici A; Simons K; Brüstle O; Koch P; Haass C; Caflisch A; Rajendran L
    Cell Rep; 2016 Mar; 14(9):2127-2141. PubMed ID: 26923602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.
    Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO
    Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.